D. E. Shaw & Co., L.P. 13D/13G Filings for CymaBay Therapeutics, Inc. (CBAY)

D. E. Shaw & Co., L.P. 13D and 13G filings for CymaBay Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2021-02-16
4:04 pm
Sale
2020-12-3113GCymaBay Therapeutics, Inc.
CBAY
D. E. Shaw & Co., L.P.1,260,749
1.800%
-2,188,863decrease
(-63.45%)
Filing
2020-06-05
4:02 pm
Purchase
2020-05-2613GCymaBay Therapeutics, Inc.
CBAY
D. E. Shaw & Co., L.P.3,449,612
5.000%
3,449,612increase
(New Position)
Filing